ReShape Lifesciences (RSLS) Insider Trading & Ownership $1.09 +0.06 (+5.83%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$1.04 -0.05 (-4.59%) As of 03/3/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ReShape Lifesciences (NASDAQ:RSLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.10%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$42,896.80Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$42,276.20 Get RSLS Insider Trade Alerts Want to know when executives and insiders are buying or selling ReShape Lifesciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RSLS Insider Buying and Selling by Quarter ReShape Lifesciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/25/2023Thomas StankovichCFOSell2$15.66$31.32 10/11/2023Thomas StankovichCFOSell0$53.94$0.00 9/1/2023Thomas StankovichCFOSell2$51.62$103.24 8/24/2023Thomas StankovichCFOSell0$82.36$0.00 8/4/2023Thomas StankovichCFOSell1$82.94$82.94 7/6/2023Thomas StankovichCFOSell1$85.26$85.26 6/30/2023Thomas StankovichCFOBuy305$88.16$26,888.80 5/31/2023Thomas StankovichCFOSell1$139.78$139.78 4/30/2023Thomas StankovichCFOSell1$136.88$136.88 3/31/2023Thomas StankovichCFOSell1$150.80$150.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/28/2023Thomas StankovichCFOSell1$246.50$246.50 2/2/2023Thomas StankovichCFOSell2$770.82$1,541.64 1/24/2023Thomas StankovichCFOSell2$434.42$868.84 11/4/2022Thomas StankovichCFOSell2$783.00$1,566.00 10/4/2022Thomas StankovichCFOSell2$812.00$1,624.00 9/6/2022Thomas StankovichCFOSell1$1,131.00$1,131.00 8/5/2022Barton P BandyCEOSell4$1,363.00$5,452.00 8/5/2022Thomas StankovichCFOSell1$1,363.00$1,363.00 7/1/2022Barton P BandyCEOSell3$1,595.00$4,785.00 7/1/2022Thomas StankovichCFOSell1$1,595.00$1,595.00 6/1/2022Barton P BandyCEOSell3$2,755.00$8,265.00 5/31/2022Thomas StankovichCFOBuy6$2,668.00$16,008.00 4/1/2022Barton P BandyCEOSell3$3,277.00$9,831.00 4/1/2022Thomas StankovichCFOSell1$3,277.00$3,277.00 (Data available from 1/1/2013 forward) RSLS Insider Trading Activity - Frequently Asked Questions Who is on ReShape Lifesciences's Insider Roster? The list of insiders at ReShape Lifesciences includes Barton P Bandy, and Thomas Stankovich. Learn more on insiders at RSLS. What percentage of ReShape Lifesciences stock is owned by insiders? 0.10% of ReShape Lifesciences stock is owned by insiders. Learn more on RSLS's insider holdings. Which ReShape Lifesciences insiders have been buying company stock? The following insider purchased RSLS shares in the last 24 months: Thomas Stankovich ($26,888.80). How much insider buying is happening at ReShape Lifesciences? Insiders have purchased a total of 305 RSLS shares in the last 24 months for a total of $26,888.80 bought. Which ReShape Lifesciences insiders have been selling company stock? The following insider sold RSLS shares in the last 24 months: Thomas Stankovich ($730.22). How much insider selling is happening at ReShape Lifesciences? Insiders have sold a total of 9 ReShape Lifesciences shares in the last 24 months for a total of $730.22 sold. ReShape Lifesciences Key ExecutivesMr. Dan W. Gladney (Age 71)Executive Chair Compensation: $129.5kMr. Paul F. Hickey (Age 59)CEO, President & Director Compensation: $506.42kMr. Thomas Stankovich (Age 63)Senior VP & CFO Compensation: $307.12kDr. Mark B. Knudson Ph.D. (Age 75)Co-Founder and Special Advisor to the CEO Compensation: $33kDr. Katherine S. Tweden Ph.D. (Age 63)Co-Founder Compensation: $338.41kMr. Al DiazVice President of Operations and R&DDr. Dov Gal D.V.M.M.B.A., VP of Regulatory Clinical Quality & Compliance OfficerJody B. DahlmanDirector of CommunicationsMr. Naqeeb A. Ansari (Age 63)Senior Vice President of Global Commercial Operations Compensation: $327.46k More Insider Trading Tools from MarketBeat Related Companies Abbott Laboratories Insider Transactions Intuitive Surgical Insider Transactions Boston Scientific Insider Transactions Stryker Insider Transactions Medtronic Insider Transactions Becton, Dickinson and Company Insider Transactions Edwards Lifesciences Insider Transactions IDEXX Laboratories Insider Transactions DexCom Insider Transactions ResMed Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:RSLS) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
